Schrodinger Inc (SDGR) Stock Price, Quote & News

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focu...

Industry: Health Information Services

Sector: Healthcare

Phone: 212 295 5800

Website: www.schrodinger.com

Address:

1540 Broadway, 24th Floor, New York, United States

bambus3001 Sep. 22 at 3:35 PM

$SDGR WerBranchenführer in der Molekularbiologie in Verbindung mit KI zu sein scheint, und grosses Interesse bei vielen Big Pharma Unternehmen zu wecken ,ist ein heisser Übernahme Kandidat auf Dauer ,.!!! Welche Mk würde es wert sein ? 《~20Mrd vieleicht 》 Börse wertet Zukunft.

0 · Reply

gratefultobe Sep. 22 at 3:06 PM

$SDGR short here short here blah blah blah. Moron. This is going up mark.my words.

0 · Reply

bambus3001 Sep. 22 at 2:28 PM

$SDGR 31 $ und der Kurs ist festgesetzt ,die grossen wollen die kurzfristigen Anleger wohl rauskicken. Ich sehe nach der Firmengründung 45 - 50 € Warten und bei Rücksetzer zukaufen ,gegen den Strom eben .

0 · Reply

ELONS_SUGAR_DADDY Sep. 22 at 2:08 PM

$SDGR selling at a high. Rates will rise next month, and their cashflow sucks. Good luck!

1 · Reply

BB_88_ Sep. 22 at 1:43 PM

$SDGR short 30.5

1 · Reply

bambus3001 Sep. 22 at 10:48 AM

$SDGR Bin positiv gestimmt ,wie wenig hier bisher sich ausgetauscht wird ,ein Zeichen das noch kaum Private diese Perle kennen . Gestern war noch ein grösserer Finalumsatz ,es wird noch weiter getauscht , Guten Start heute SDGR FREUNDE!!!

0 · Reply

RBuskey106 Sep. 21 at 10:40 PM

$SDGR Took Profits today....will revisit on Pull Back

0 · Reply

scott52 Sep. 21 at 8:20 PM

$SDGR is this an AI stock again? Kathy Wood... is that you?

0 · Reply

bambus3001 Sep. 21 at 7:55 PM

$SDGR Und kommt noch ein grosser Umsatz wie die letzten wochen .? Grosse Käufer am Start?

0 · Reply

bambus3001 Sep. 21 at 7:17 PM

$SDGR Ramy Farid hält die Firma auf Kurs Weiter so und es kommen noch viele gute News Davon bin Ich überzeugt .

1 · Reply

Schrodinger reports inducement grants under Nasdaq listing rule

Sep 17, 2026, 8:30 AM EDT - 5 days ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Sep 14, 2026, 1:05 PM EDT - 8 days ago

Schrödinger Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

2026-09-09T11:10:50.000Z - 13 days ago

Schrodinger announces licensing, collaboration agreement with Tectora

Sep 9, 2026, 7:00 AM EDT - 13 days ago

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

Sep 1, 2026, 8:30 AM EDT - 21 days ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

2026-08-16T13:52:46.000Z - 5 weeks ago

Schrodinger assumed with a Neutral at UBS

2026-08-16T13:19:59.000Z - 5 weeks ago

Schrodinger reports inducement grants under Nasdaq listing rule

2026-08-05T20:50:58.000Z - 6 weeks ago

Schrodinger raises FY26 drug discovery revenue view $65M-$75M from $55M-$65M

Aug 5, 2026, 4:30 PM EDT - 6 weeks ago

Schrödinger Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 6 weeks ago

Schrödinger Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 6 weeks ago

Schrödinger Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 6 weeks ago

Schrödinger Slides: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 6 weeks ago

Schrödinger Reports Second Quarter 2026 Financial Results

2026-08-05T14:13:22.000Z - 6 weeks ago

Schrodinger announces collaboration, software agreement with Bristol Myers

BMY

Aug 5, 2026, 8:30 AM EDT - 6 weeks ago

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

BMY

2026-07-27T11:35:48.000Z - 1 month ago

Schrodinger introduces Bunsen AI co-scientist for molecular discovery

GOOG GOOGL NVDA

Jul 27, 2026, 7:30 AM EDT - 1 month ago

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

Jul 22, 2026, 8:30 AM EDT - 2 months ago

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

2026-07-20T12:40:40.000Z - 2 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

Jun 22, 2026, 12:00 PM EDT - 3 months ago

Schrödinger Transcript: AGM 2026

2026-06-18T12:54:39.000Z - 3 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

May 19, 2026, 2:05 PM EDT - 4 months ago

Schrödinger Transcript: RBC Capital Markets Global Healthcare Conference 2026

2026-05-14T16:24:26.000Z - 4 months ago

Schrodinger price target lowered to $17 from $19 at Morgan Stanley

May 13, 2026, 5:20 PM EDT - 4 months ago

Schrödinger Transcript: Bank of America Global Healthcare Conference 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 months ago

Schrödinger Slides: Q1 2026

May 5, 2026, 4:05 PM EDT - 4 months ago

Schrödinger Reports First Quarter 2026 Financial Results

May 4, 2026, 8:30 AM EDT - 4 months ago

Schrödinger to Participate in Upcoming Investor Conferences

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Schrödinger Proxy statement: Proxy filing

Apr 21, 2026, 8:30 AM EDT - 5 months ago

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

2026-04-17T12:52:03.000Z - 5 months ago

Schrodinger reports inducement grants under Nasdaq listing rule

2026-04-13T10:44:45.000Z - 5 months ago

Schrodinger price target lowered to $20 from $25 at KeyBanc

Mar 17, 2026, 9:00 AM EDT - 6 months ago

Schrödinger Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

2026-03-17T12:40:30.000Z - 6 months ago

Schrodinger price target lowered to $13 from $18 at UBS

Mar 10, 2026, 1:40 PM EDT - 6 months ago

Schrödinger Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 9:50 AM EST - 6 months ago

Schrödinger Transcript: TD Cowen 46th Annual Health Care Conference

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 6 months ago

Schrödinger Slides: Q4 2025

Feb 25, 2026, 4:05 PM EST - 6 months ago

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 11, 2026, 8:30 AM EST - 7 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

Jan 12, 2026, 8:30 AM EST - 8 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Jan 9, 2026, 7:04 AM EST - 8 months ago

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

LLY

Jan 9, 2026, 7:00 AM EST - 8 months ago

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

Nov 19, 2025, 11:00 AM EST - 10 months ago

Schrödinger Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Schrödinger Slides: Q3 2025

Nov 5, 2025, 4:05 PM EST - 10 months ago

Schrödinger Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 7:30 AM EDT - 10 months ago

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger

Oct 22, 2025, 8:30 AM EDT - 11 months ago

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Schrödinger Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Second Quarter 2025 Financial Results

Jul 25, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Jul 18, 2025, 10:25 AM EDT - 1 year ago

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Jul 17, 2025, 8:00 AM EDT - 1 year ago

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

$Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia$

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Jun 18, 2025, 12:00 PM EDT - 1 year ago

Schrödinger Transcript: AGM 2025

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Transcript: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Press release: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Slides: Status Update

Jun 12, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Jun 4, 2025, 1:25 PM EDT - 1 year ago

Schrödinger Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 5:00 PM EDT - 1 year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 28, 2025, 12:22 PM EDT - 1 year ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB ILMN NVS

May 22, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Jefferies Global Healthcare Conference

May 20, 2025, 6:30 AM EDT - 1 year ago

Schrödinger Announces CFO Appointment

May 14, 2025, 4:40 PM EDT - 1 year ago

Schrödinger Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 9:30 AM EDT - 1 year ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

bambus3001 Sep. 22 at 3:35 PM

0 · Reply

gratefultobe Sep. 22 at 3:06 PM

$SDGR short here short here blah blah blah. Moron. This is going up mark.my words.

0 · Reply

bambus3001 Sep. 22 at 2:28 PM

0 · Reply

ELONS_SUGAR_DADDY Sep. 22 at 2:08 PM

$SDGR selling at a high. Rates will rise next month, and their cashflow sucks. Good luck!

1 · Reply

BB_88_ Sep. 22 at 1:43 PM

$SDGR short 30.5

1 · Reply

bambus3001 Sep. 22 at 10:48 AM

0 · Reply

RBuskey106 Sep. 21 at 10:40 PM

$SDGR Took Profits today....will revisit on Pull Back

0 · Reply

scott52 Sep. 21 at 8:20 PM

$SDGR is this an AI stock again? Kathy Wood... is that you?

0 · Reply

bambus3001 Sep. 21 at 7:55 PM

$SDGR Und kommt noch ein grosser Umsatz wie die letzten wochen .? Grosse Käufer am Start?

0 · Reply

bambus3001 Sep. 21 at 7:17 PM

$SDGR Ramy Farid hält die Firma auf Kurs Weiter so und es kommen noch viele gute News Davon bin Ich überzeugt .

1 · Reply

BB_88_ Sep. 21 at 6:49 PM

$SDGR scalps working so far today short 30.9

0 · Reply

BB_88_ Sep. 21 at 4:51 PM

$SDGR round two short 30.54

0 · Reply

BB_88_ Sep. 21 at 3:47 PM

$SDGR will try a short here 30.57

1 · Reply

bambus3001 Sep. 21 at 3:27 PM

$SDGR Vor 3Jahren ca.50 $ kurz gesehen und heute 2026 steht das Unternehmen deutlich besser da,es läuft Gut! Also welche Ziele sind möglich in der Zukunft. KI mit Biopharma, Einfach mal mit anderen KI vergleichen, die vor 5 Jahren auch noch unentdeckt waren .Bleib ein Optimist.

0 · Reply

bambus3001 Sep. 21 at 7:46 AM

$SDGR Neue Woche Bin mal gespannt wieviel Volumen diese Woche getauscht wird .? Glaube die grossen sind viele noch nicht dabei ,und wer grosse Pakete schon länger sammelt ,plant wohl weiter. Bin gespannt und halte geduldig diese Zukunftsperle mit KI 👌

0 · Reply

abishop717 Sep. 20 at 12:32 AM

Still holding $BOOT $EPD $SDGR $CMPS

0 · Reply

No_Face_character Sep. 19 at 8:47 PM

$SDGR hmmm. watching.

0 · Reply

madnessofcrowds Sep. 19 at 2:39 AM

$SDGR I’m sure it’s nothing

0 · Reply

DynamicCapital Sep. 19 at 1:35 AM

$SDGR as posted on Sept 4th. Positive news flow from the company involving the collaboration/ creation with Tectora as a second stage derivative play in AI genomic drug discovery. Noteable trading volumes, a steadily rising RSI. Please do your own DD on this one.

0 · Reply

bambus3001 Sep. 18 at 8:39 PM

$SDGR Wenn Ich den Wochenchart so sehe ,will der Kurs weiter Gen Norden . Ruhe bewahren ist nicht immer einfach nach den Anstieg der letzten wochen . Ich übe Geduld, denn Börse braucht Geduld. Kostolany hat es ewig gepredigt.!!!!

0 · Reply

bambus3001 Sep. 18 at 8:23 PM

$SDGR Und wieder zum schluss grosse Pakete tauschen. Irgendwas läuft hinter den Kulissen!

0 · Reply

trader365 Sep. 18 at 7:21 PM

$SDGR $TEM $TWST The convergence of AI and healthcare remains a compelling long-term thesis.

0 · Reply

Market Cap	2.14B
Revenue (ttm)	255.87M
Net Income (ttm)	-103.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.36%
Debt to Equity Ratio	0.00

Volume	1,754,574
Avg Vol	1,402,534
Day's Range	N/A - N/A
Shares Out	73.83M
Stochastic %K	94%
Beta	1.69
Analysts	Strong Sell
Price Target	$21.43